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Introduction
Persistent digestive disorders can be defined as any diarrhea (i.e., three or more loose stools per
day) lasting for at least two weeks and/or abdominal pain that persists for two weeks or longer
[1–3]. These disorders cause considerable morbidity and human suffering, and hence, are rea-
sons why people might seek primary health care. However, in resource-constrained settings of
the tropics and subtropics, accurate point-of-care diagnostics are often lacking and treatment
is empiric, particularly in remote rural areas with no laboratory infrastructure.As a result, the
relative contribution of selected pathogens to the syndrome of persistent digestive disorders is
poorly understood, and evidence-basedguidelines for patient management in different social-
ecological settings are scarce [4–6].
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004818 November 3, 2016 1 / 13
a11111
OPENACCESS
Citation: Becker SL, Yap P, Horie´ NS, Alirol E,
Barbe´ B, Bhatta NK, et al. (2016) Experiences and
Lessons from a Multicountry NIDIAG Study on
Persistent Digestive Disorders in the Tropics. PLoS
Negl Trop Dis 10(11): e0004818. doi:10.1371/
journal.pntd.0004818
Editor: Serap Aksoy, Yale School of Public Health,
UNITED STATES
Published: November 3, 2016
Copyright: © 2016 Becker et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Funding: This work is part of the NIDIAG European
research network (Collaborative Project),
supported by the European Union’s Seventh
Framework Programme for research, technological
development, and demonstration under grant
agreement no. 260260. The funders had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
In order to improve the clinical management of patients with disorders caused by neglected
tropical diseases (NTDs), the European Commission (EC) funded a five-year study—the
Neglected Infectious diseasesDIAGnosis (NIDIAG) research consortium. The overarching goal
of the NIDIAG consortium is to develop and validate patient-centered diagnosis–treatment guide-
lines for use at the primary health care level in low- and middle-income countries (http://www.
nidiag.org) [3,7–9]. Emphasis is placed on three syndromes: (i) persistent digestive disorders
describedhere; (ii) persistent fever; and (iii) neurological disorders, the latter two of which are
detailed in companion pieces published in the same issue of PLOS Neglected Tropical Diseases.
With regard to the study on persistent digestive disorders, the main aims are (i) to identify the
most important NTDs and other infectious agents that give rise to this clinical syndrome, includ-
ing their relative frequency; (ii) to assess and compare the accuracy of different diagnosticmeth-
ods; and (iii) to determine clinical responses to commonly employed empiric treatment options
for persistent digestive disorders [9]. To this end, a case–control study has been implemented in
four countries: Côte d’Ivoire andMali inWest Africa and Indonesia and Nepal in Asia. An inte-
gral part of the NIDIAG consortium is to ensure that good clinical practice (GCP) and good clin-
ical laboratory practice (GCLP) are adhered to while conducting the studies [10,11]. A quality
assurance system, which included the development and implementation of a set of standard
operating procedures (SOPs), along with on-the-spot staff training and internal and external
quality control activities, has been developed at the project level and introduced at each study
site. The development of, and adherence to, SOPs within harmonized study protocols were con-
sidered crucial steps for maximizing the integrity of laboratory and clinical data across study set-
tings. They also provided the basis on which quality control activities could be performed.
For Which Procedures Have SOPs Been Developed?
For the study on persistent digestive disorders, 33 specific SOPs have been developed (Supporting
Information). As summarized in Table 1, detailed steps on clinical and laboratory procedures,
data management, and quality assurance were described.With regard to clinical investigations,
SOPs on history taking and clinical examination, assessing inclusion and exclusion criteria,
patient recruitment, and study flowwere developed (S1-S6). Detailed instructions on how to per-
form a set of laboratory diagnostic techniques for the detection of helminth and intestinal proto-
zoa infections were included in the laboratory SOPs. Different conventional stool microscopy
techniques were combined with more recent rapid antigen detection tests to encompass a broad
spectrumof potentially implicated pathogens with high diagnostic accuracy (S7-S20). An over-
view of the employed diagnosticmethods is provided in Table 2. Pertaining to data management,
SOPs on completion of case report forms (CRFs) and on various activities (such as data entry,
data cleaning, querying, database locking, and backing up data) were also included. To ensure
quality control, SOPs on internal quality control activities, external monitoring, and laboratory
supervision visits were jointly developed for the three syndromes (S21-S33).
Of note, all SOPs were developed in English (for use in Nepal) and subsequently translated
into French (for use in Côte d’Ivoire and Mali) and Bahasa Indonesia (for use in Indonesia).
This comprehensive set of closely interconnected SOPs—which provides guidance on all essen-
tial procedures from the first presentation of an individual at a health care center until the final
processing of all patient and laboratory data—is displayed in Fig 1.
How Was the Development of SOPs Coordinated, and Which Quality
Control Measures Were Adopted?
The development and harmonization of the various SOPs was coordinated by the quality assur-
ance group of the NIDIAG consortium and the trial management group (TMG) of the
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digestive syndrome study and followed a standard template and consortium-wide guidelines
stipulated in the SOP entitled “SOP on SOP” (S24). This allowed different authors with varied
background and writing styles to convey key messages and pass on their expert knowledge in a
systematic, standardizedmanner for the benefit of the end user of all the SOPs. In addition, it
provided clear instructions on how the SOPs should be numbered, reviewed, and approved to
allow for strict version control. The authors of the SOPs were chosen from within the NIDIAG
consortium, and allocation of topics was based on expertise and track record in the clinical, lab-
oratory, data management, and quality assurance components of the study. Experts in the field,
at the bench, and at the bedside carefully reviewed and revised the draft SOPs. Before the start
of recruitment, local clinical and laboratory teams were trained on the set of SOPs through two
hands-on workshops lasting three days each that were conducted on site by relevant experts of
Table 1. Set of standard operating procedures (SOPs) used in the NIDIAG study on persistent digestive disorders.
Number Type Purpose of SOP End user Syndrome
1 Clinical History taking Site investigator Digestive
2 Clinical Clinical examination Site investigator Digestive
3 Clinical Selection of controls without digestive syndrome Site investigator Digestive
4 Clinical Specific treatment procedures (including dosage) Site investigator Digestive
5 Clinical Assessing inclusion and exclusion criteria Site investigator Digestive
6 Clinical Patient recruitment and patient flow Site investigator Digestive
7 Laboratory Kinyoun staining technique Laboratory technician Digestive
8 Laboratory Modified acid-fast staining technique Laboratory technician Digestive
9 Laboratory Crypto/Giardia Duo-Strip rapid diagnostic test (RDT) Laboratory technician Digestive
10 Laboratory Kato-Katz thick smear technique Laboratory technician Digestive
11 Laboratory Baermann funnel concentration technique Laboratory technician Digestive
12 Laboratory Mini-FLOTAC technique Laboratory technician Digestive
13 Laboratory How to obtain a stool sample Laboratory technician Digestive
14 Laboratory Formalin-ether concentration technique Laboratory technician Digestive
15 Laboratory Koga agar plate culture Laboratory technician Digestive
16 Laboratory Direct fecal smear technique Laboratory technician Digestive
17 Laboratory Preparation of aliquots for molecular post-hoc testing Laboratory technician Digestive
18 Laboratory Urine point-of-care circulating cathodic antigen (POC-CCA) RDT
for the diagnosis of Schistosoma mansoni
Laboratory technician Digestive
19 Laboratory Diagnostic sample flow Laboratory technician Digestive
20 Laboratory Urine sampling Laboratory technician Digestive
21 Quality Obtaining informed consent Site investigator Common
22 Quality Numbering system to be used in NIDIAG studies Laboratory technician Digestive
mainly
23 Quality Management of study documents Principal investigator (PI)/site investigator/
nurse/laboratory technician
Common
24 Quality SOP on SOPs SOP author Common
25 Quality External monitoring PI/site investigator Common
26 Quality Internal quality control activities Quality manager Common
27 Quality Good clinical laboratory practice (GCLP) supervision visits Quality manager Common
28 Quality Min/max thermometer Laboratory technician Common
29 Quality Stock management Laboratory technician Common
30 Quality Handling of expired and disqualified products Laboratory technician Common
31 Quality Handling and storage of rapid diagnostic tests Laboratory technician Digestive
32 Data Completing case report forms (CRFs) Site investigator Common
33 Data Procedure for data management Data manager Digestive
doi:10.1371/journal.pntd.0004818.t001
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the NIDIAG consortium.During these workshops, feedback from the local partners was incor-
porated to refine the already developed SOPs, and additional SOPs were jointly developed to
meet specific demands of local clinical, epidemiologic, and laboratory conditions. For example,
in Indonesia, where Kinyoun staining was not available, an SOP pertaining to a slightly modi-
fied acid-fast staining technique was developed for the local team instead. Finally, once an SOP
was finalized, a member of the TMG would approve it. A quality assurance member of the
NIDIAG consortiumwas tasked to compile and keep updated the final set of SOPs and ensure
that the latest versions were available on the NIDIAG intranet for distribution among the dif-
ferent country partners.
Which Patient Recruitment Patterns Have Been Observed?
In clinical trials and case–control studies, it is one of the most difficult tasks to precisely define
patient inclusion and exclusion criteria and to carry out the enrolment accordingly under “real
life” conditions, thereby minimizing selection bias [12]. Apart from a specific study protocol
and a given research question, several studies have shown that many internal and external fac-
tors may considerably influence the pace of patient recruitment in clinical trials. Many of these
factors are not related to scientific issues, such as the workload for study staff who are responsi-
ble for the recruitment of patients, the distance between the study center and the place of resi-
dence of potential participants, insufficient engagement with the community, and the
complexity of consent procedures prior to the start of patient enrollment [13,14]. In the
NIDIAG study pertaining to persistent digestive disorders, several site assessments were car-
ried out in the four countries before launching the larger multicountry study [15]. It was
Table 2. Laboratory diagnostic techniques used and internally compared in the NIDIAG study on persistent digestive disorders.
Diagnostic technique Target pathogen(s)
Soil-transmitted helminths Schistosoma mansoni Strongyloides stercoralis Intestinal protozoa
Direct fecal smear (✓) (✓) (✓) (✓)
Kato-Katz thick smear ✓ ✓ – –
Formalin-ether concentration ✓ ✓ (✓) ✓
Mini-FLOTAC ✓ ✓ – (✓)a
Baermann funnel concentration (✓)b – ✓ –
Koga agar plate culture (✓)b – ✓ –
RDT for Cryptosporidium and Giardia
intestinalis
– – – ✓c
POC-CCA urine cassette test – ✓ – –
Acid-fast staining procedure – – – ✓d
The laboratory diagnostic techniques consisted of microscopic methods and rapid diagnostic tests (RDTs). They were used and compared within the
NIDIAG study on persistent digestive disorders, placing particular emphasis on the suitability for the detection of helminths and intestinal protozoa that may
give rise to persistent digestive disorders (2 weeks). The following grading system was employed to characterize the suitability of a certain laboratory
technique for the detection of specific pathogens:✓ suitable; (✓) partially suitable; –not suitable.
Of note, additional bacteriologic stool cultures were performed in all countries except Indonesia in case of diarrheic stool samples.
aVery limited published data, according to which FLOTAC techniques may detect some intestinal protozoa species (e.g., G. intestinalis), but further
validation of the technique for this use is required.
bHookworm larvae can be detected, in particular by culture. Additionally, hookworm larvae can be found using the Baermann technique, if the stool sample
has been kept long enough for the eggs to hatch.
cThis RDT detects only Cryptosporidium spp. and G. intestinalis.
dAcid-fast staining methods (e.g., Kinyoun stain) are particularly suitable for the detection of Cryptosporidium spp., Cyclospora cayetanensis, and
Cystoisospora belli that are easily missed by most other microscopic diagnostic techniques.
doi:10.1371/journal.pntd.0004818.t002
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decided that a case–control design should be adopted [16–18] and that the ideal target sample
size in each country would be in the range of 500 symptomatic patients and 500 asymptomatic
controls. After obtaining all the necessary ethics approvals (August 2013–January 2014), exten-
sive study document and site preparations, and GCP/GCLP training of the study site staff, the
first patient was recruited in Nepal on July 30, 2014.
Interestingly, the recruitment of patients and controls showed considerable heterogeneity
across countries. Fig 2 displays the country-specificenrolment over time. In Mali, where almost
exclusively patients with persistent abdominal pain (and very few with persistent diarrhea)
were recruited, the numbers of eligible patients and controls were high, and the recruitment
went smoothly and without major obstacles. Indeed, a total of 553 patients and 553 matched
controls were enrolled by May 2015, when the study was deemed successfully completed in
Mali.
A different pattern was observed in Nepal. Patient recruitment started well in July and
August 2014 but was temporarily interrupted for a period of almost three months because of
Fig 1. Principal elements of the NIDIAG digestive study and the respective standard operating procedures (SOPs) used.
doi:10.1371/journal.pntd.0004818.g001
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protracted strikes and civil unrest that limited freedomof movement of the people. Later,
patient enrolment resumed at a stable recruitment pace (with some seasonality seen) until
August 2015, when nationwide strikes again affected the number of enrolled patients such that
the initially targeted sample size of 500 symptomatic patients and 500 controls could not be
reached.
A slow recruitment rate was observed in Côte d’Ivoire during the first months of the study,
which was mainly explained by the fact that few eligible patients presented to the study hospi-
tal, whereas higher numbers of patients with either persistent diarrhea or persistent abdominal
pain were reported from rural, remote health care posts in the surroundings of the study hospi-
tal. Hence, the recruitment was changed from a mainly passive approach—i.e., waiting for
symptomatic patients to present to the study hospital—to a more proactive enrolment strategy,
which included informing health care workers in the peripheral health care institutions and vil-
lages about the purpose and scope of the study so that they could actively refer potentially eligi-
ble patients to the study team.
A similar proactive approach was adopted in Indonesia, but the number of enrolled patients
with persistent digestive disorders remained very low. Hence, after five months (August 2014–
January 2015), it was decided by the study country team and the TMG to interrupt the study
Fig 2. Country-specific enrolment characteristics of patients and controls in the NIDIAG study on persistent digestive disorders.
doi:10.1371/journal.pntd.0004818.g002
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prematurely and to modify the design. Subsequently, a large community-based surveywas car-
ried out in the study area—which employed the same suite of diagnosticmethods as foreseen
in the original study protocol—to improve the diagnosis of parasitic infections and to increase
the understanding of the causes and the clinical features that are related to these infections in
rural Indonesia. The respective ethics committees were readily informed about the necessary
modifications, and approval was obtained before the start of the survey.
What Were Key Challenges During Patient Recruitment?
During the course of the NIDIAG digestive study, several challenges were encountered that
underscore why it remains an ambitious goal to perform studies on neglected clinical syn-
dromes in the tropics. First, most study investigators reported difficulties in recruiting patients
with persistent diarrhea as defined by theWorld Health Organization (WHO)—i.e., any diar-
rhea lasting for at least 14 days [2]. Indeed, while long-lasting diarrheal diseases were perceived
as a relevant clinical problem in all four study countries, many patients with persistent diarrhea
had previously either taken empiric treatment (i.e., antibiotics, antiparasitics, or traditional
medicines) or consulted a health care professional (e.g., village health center or local phar-
macy). In this context, it is important to note that antidiarrheal medication and anti-infective
drugs are regularly available as over-the-counter drugs without prescription in many low- and
middle-income countries and are thus easily accessible [19,20]. Such medical and pharmaceuti-
cal interventions probably led to partial, transitory improvement in some patients, but the
digestive symptoms returned after variable periods of intermittence in a considerable propor-
tion of study participants. However, such patients frequently failed to meet the actual inclusion
criteria because the onset of diarrheal symptoms after 2 days without diarrhea was defined as a
new episode [9], and some of them could thus not be included.
Second, diarrhea and abdominal pain are relatively vague, subjective symptoms, and their
reported severity depends on the perceived concepts of illness of the individual patient [21].
Previous studies have shown that the length of the recall period is inversely related to the accu-
racy and reliability of reported patient complaints and that less severe episodes of diarrhea can
be up to 40% underreported,with a recall period of one week [22]. Furthermore, there is evi-
dence from resource-constrained settings that diarrhea is less likely to be reported as a per-
ceived health problem if it is common in a specific area [23,24]. For obvious reasons,
“persistent abdominal pain” is evenmore difficult to define and to objectively retrace. The
application of a standardizedmedical examination as part of the routine workup in the
NIDIAG digestive study was thus considered an essential tool to complement data gathering
and to counterbalance inaccuracies obtained by self-assessedmorbidity reports.
Third, the NIDIAG digestive study was noninterventional, and study site–specific factors
had thus to be considered. In Nepal, for instance, there are considerable government-runmass
drug administration (MDA) campaigns that may have led to a decrease of helminthiasis-asso-
ciated diarrheal diseases. Indeed, biannual deworming with albendazole for children aged 12–
59 months has been carried out along with vitamin A supplementation since 1999, and alben-
dazole is given twice a year to children attending grades one through ten of all public and pri-
vate schools. Since 2005, albendazole has also been administered along with
diethylcarbamazine citrate (DEC) as part of the efforts to eliminate lymphatic filariasis, and
Nepal is expected to complete six rounds of MDA in 2018. Finally, pregnant women are also
given albendazole during their second trimester. Hence, nearly all age groups in Nepal may
potentially receive this anthelmintic drug through one of theseMDA campaigns, and it will be
interesting to see whether the NIDIAG study results confirm a beneficial effect on helminth-
associated persistent digestive disorders.
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Fourth, the etiology of persistent diarrhea and persistent abdominal pain is manifold and
not limited to infectious causes. Autoimmune disorders, inflammatory diseases, neoplasms,
and specific food intolerances may, among others, also lead to persistent intestinal disorders
[25]. The researchers and clinicians on site experienced that this fact needs to be explained in
detail to symptomatic patients without an identified pathogen, and further investigations or
referral to additional diagnostics should be initiated promptly. Of note, the detection of a cer-
tain pathogen in a stool or urine sample does not necessarilymean that the patient’s symptoms
are actually linked to this finding [26]. As the proportion and quantity of encountered patho-
gens may vary considerably from one setting to another, the NIDIAG study employed a case–
control approach to elucidate pathogen-specific attributable fractions to the syndrome of per-
sistent digestive disorders [27,28].
Controls were recruited from the same study centers as the symptomatic patients and were
furthermatched by age group and sex to the symptomatic cases. It proved to be difficult to
obtain consent of individuals to act as controls because they were frequently wondering why
someone would be interested in analyzing stool and urine samples of healthy individuals.
While careful explanation—being particularly sensitive to potential cultural barriers—helped
to clarify this, some individuals still considered stool samples as very personal, intimate speci-
mens and refused to participate. Indeed, the Nepalese study sites observed that it was very diffi-
cult to include asymptomatic patients who were unrelated to a symptomatic patient, while it
was relatively straightforward to obtain consent from friends, relatives, or neighbors of symp-
tomatic cases with persistent diarrhea, potentially because these individuals shared similar
exposure characteristics (e.g., source of drinkingwater) with the symptomatic patient and
wanted to know whether they were found to carry the same intestinal pathogens.
Have Challenges of Specific Laboratory Techniques Been Observed,
and Which Solutions Have Been Adopted?
Two main areas of laboratory-associated challenges were identified during the NIDIAG diges-
tive study: (i) general infrastructure and equipment and (ii) the conduct of the diagnostic labo-
ratory tests. First, it was noted during the pre-study field visits that the available laboratory
infrastructure in the study countries was, at most sites, not sufficient to accommodate such a
broad diagnostic test panel as indicated by the NIDIAG study protocol [3]. Indeed, there was
no laboratory that had routinely employed all of the methods before the onset of the study.
Hence, workshops were held to familiarize study staff with the techniques and to harmonize
procedures across study countries. Additionally, many efforts were required to establish an
internal and external quality assurance and monitoring system so that GCP/GCLP standards
were met. It is important to note that such preparatory work is essential to ensure the proper
conduct of scientific studies, but the significant human, logistic, and financial resources
required are usually not considered sufficiently beforehand by both scientists and funding
organizations [29]. In Indonesia, the complete laboratory infrastructure had to be set up in a
remote area of an island where the study center was located, which required several weeks of
constructionwork. A short video showing the different study procedures as well as the labora-
tory infrastructure before and after the onset of the NIDIAG study in Maluku Tengah can be
found in the supplementary material of this manuscript (S34). Of note, evenminor logistic
issues may have a profound impact. In Côte d’Ivoire and Nepal, for example, the absence of a
functioning ventilation and climate control system in the laboratories led to several short
delays in recruitment and specimen processing, as stool samples are unpleasant to work with
and the study was thus not initiated before the ventilation systems were fixed.
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Study site investigators frequently reported that the volume of a single stool sample was
smaller than the amount stipulated in the respective SOP and was thus not sufficient to per-
form all required laboratory tests. Indeed, an amount of approximate 80 g of stool was required
to run all tests (Table 2), as several diagnostic techniques (such as the Baermann funnel con-
centration for the diagnosis of Strongyloides stercoralis) require a large amount of stool. In such
cases, a second sample had to be obtained from participants, but some, especially children,
were not always able to provide the required amount and sometimes did not come back to pro-
vide the requested second sample.
Because of the host of different laboratory tests, the processing of a sample took approxi-
mately two to three hours, and it would have been ideal to collect stool specimens in the early
morning and analyze them immediately in the laboratory. However, this was not always possi-
ble as the sites of patient enrolment were sometimes quite distant from the actual laboratory
(e.g., the Dhankuta study site in Nepal) or the study laboratories had to send parts of the sam-
ple to reference laboratories (e.g., in Côte d’Ivoire and Mali, for stool bacteriology in case of
persistent diarrhea). Such sample transfer had to be organized and carried out by couriers,
such that laboratory staff sometimes worked until late in the evening when a sample arrived
only in the afternoon.
With regard to difficulties associated with specific laboratory techniques, few deviations
were observed, and the study investigators complied very well with the various SOPs. This
observationwas largely attributed to the two in-depth preparatory workshops that had taken
place prior to the start of the study. Some of the remaining challenges experienced and poten-
tial solutions to overcome these are presented in Table 3.
Conclusions
As the NIDIAG project draws to an end, we feel that experiences and lessons learnt must be
shared with the broader research community, clinicians, and disease control managers in coun-
tries where digestive disorders due to NTDs remain an important public health issue (Box 1).
The current set of field-tested and ready-to-use SOPs has been implemented successfully in
various sites, including those located in areas with restricted resources.We hope that providing
Table 3. Diagnostic challenges encountered during the NIDIAG study on persistent digestive disorders and proposed solutions.
Diagnostic test Problem Possible reason Solution
RDT for
Cryptosporidium and
Giardia
Faintly positive test line that is hard to
interpret as either a positive or negative
test result
An inaccurate volume of stool sample may
have been used
While an exact amount of liquid stool could
easily be taken via pipettes, this was less
standardized for solid samples. All positive
or faintly positive RDT results were
documented by photography, and results
should be compared to subsequent
microscopic and molecular diagnostics
RDT for
Cryptosporidium and
Giardia
During internal quality control, a
Cryptosporidium-positive stool sample
led to inconsistent results upon RDT
application
False-negative results were exclusively
observed on expired or nearly expired RDTs
Strict adherence to the indicated expiration
dates of RDTs in clinical studies and
routine diagnostics
Formalin-ether
concentration
Difficult microscopic reading of stool
samples following formalin-ether
concentration
Questionable quality of the locally obtained
ether
Identify alternative provider for ether and
other chemical products required for
analysis (proved to be difficult in some
study countries)
Mini-FLOTAC Leakage of one flotation chamber The utilized Mini-FLOTAC apparatus can be
reused after disinfection. However, the
washing procedure may influence the
stability of the flotation chambers
Apply vaseline on the septum or partition of
the Mini-FLOTAC to prevent leakage
doi:10.1371/journal.pntd.0004818.t003
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open access to this large compilation of SOPs and highlighting key challenges met during the
implementation and the conduct of the NIDIAG study on persistent digestive disorders might
assist in further training and capacity building on all aspects of patient recruitment, clinical
and diagnostic workup within GCP/GCLP standards, data management, and quality control,
and thus improve the clinical diagnostic algorithms for patients suffering fromNTDs. We look
forward to experiences and lessons by other groups pursuing syndromic approaches to advance
the diagnosis and clinical management of NTDs among neglected populations.
Supporting Information
S1 Clinical SOP. History taking.
(PDF)
S2 Clinical SOP. Clinical examination.
(PDF)
S3 Clinical SOP. Selectionof controls without digestive syndrome.
(PDF)
S4 Clinical SOP. Specific treatment procedures (including dosage).
(PDF)
S5 Clinical SOP. Assessing inclusion and exclusion criteria.
(PDF)
S6 Clinical SOP. Patient recruitment and patient flow.
(PDF)
Box 1. Key Learning Points from the Multicountry NIDIAG Study on
Persistent Digestive Disorders in the Tropics
• There is a need for studies investigating the etiology, diagnosis, and management of
common clinical syndromes such as persistent digestive disorders in the tropics. Easily
applicable, evidence-baseddiagnosis–treatment algorithms could substantially
improve the clinical management of such syndromes at the primary health care level.
• The implementation of a quality assurance system is crucial for conductingmulticenter
clinical studies in resource-restricted settings, and it remains an ambitious goal to per-
form studies that fully comply with GCP and GCLP.
• Study documents such as SOPs and CRFs should be jointly developed and validated to
harmonize procedures across study sites. Such field-tested tools are an important
resource for researchers and health care staff and should thus be made publicly
available.
• In a study on persistent digestive disorders, which was carried out by the NIDIAG con-
sortium, perceived challenges were the prolonged recall period (14 days) for the iden-
tification of individuals with persistent abdominal pain and persistent diarrhea and the
considerable heterogeneity seen regarding the recruitment pace of patients and con-
trols in the four study countries.
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S1 LaboratorySOP. Kinyoun staining technique (used in Côte d’Ivoire, Mali, and Nepal).
(PDF)
S2 LaboratorySOP. Modified acid-fast staining technique (used in Indonesia).
(PDF)
S3 LaboratorySOP. Crypto/GiardiaDuo-Strip rapid diagnostic test (RDT).
(PDF)
S4 LaboratorySOP. Kato-Katz thick smear technique.
(PDF)
S5 LaboratorySOP. Baermann funnel concentration technique.
(PDF)
S6 LaboratorySOP. Mini-FLOTAC technique.
(PDF)
S7 LaboratorySOP. How to obtain a stool sample.
(PDF)
S8 LaboratorySOP. Formalin-ether concentration technique.
(PDF)
S9 LaboratorySOP. Koga agar plate culture.
(PDF)
S10 LaboratorySOP. Direct fecal smear technique.
(PDF)
S11 LaboratorySOP. Preparation of aliquots for molecularpost-hoc testing.
(PDF)
S12 LaboratorySOP. Urine point-of-care circulating cathodic antigen (POC-CCA)RDT
for the diagnosis of Schistosomamansoni.
(PDF)
S13 LaboratorySOP. Diagnostic sample flow.
(PDF)
S14 LaboratorySOP. Urine sampling.
(PDF)
S1 Quality SOP. Obtaining informed consent.
(PDF)
S2 Quality SOP. Numbering system to be used in NIDIAG studies.
(PDF)
S3 Quality SOP. Management of study documents.
(PDF)
S4 Quality SOP. SOP on SOP.
(PDF)
S5 Quality SOP. Externalmonitoring.
(PDF)
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S6 Quality SOP. Internal quality control activities.
(PDF)
S7 Quality SOP. Good clinical laboratory practice (GCLP) supervisionvisits.
(PDF)
S8 Quality SOP. Min/max thermometer.
(PDF)
S9 Quality SOP. Stock management.
(PDF)
S10 Quality SOP. Handling of expired and disqualifiedproducts.
(PDF)
S11 Quality SOP. Handling and storage of rapid diagnostic tests (RDTs).
(PDF)
S1 Data management SOP. Completing case report forms (CRFs).
(PDF)
S2 Data management SOP. Procedure for data management.
(PDF)
S1 Video. The NIDIAG study site in Maluku Tengah, Indonesia.
(7Z)
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